VetCell’s StemRegen – the original and best stem cell therapy for equine tendon injuries

By Stem Cell Treatment

Equine Stem Cell Therapy "Following our recent published research on VetCell-treated horses, we are now confident that VetCell's stem cell treatment (now known as StemRegen) is currently the best way to treat an overstrain injury of the superficial digital flexor tendon." Prof. Roger Smith MA VetMB PhD DipECVS DEO MRCVS - Professor of Equine Orthopaedics, The Royal Veterinary College VetCell offers: - new research supporting stem cell treatments for equine tendon and ligament injuries - the UK's only authorised equine stem cell laboratory supplying the UK and Europe (authorised by DEFRA's Veterinary Medicines Directorate) - a money-back guarantee to show our confidence in the treatment (conditions apply) - experts in the stem cell treatment available to assist you with your first case or to offer training to groups of vets in the UK and Europe For more details please visit our website http://www.vetcell.com

See the original post here:
VetCell's StemRegen - the original and best stem cell therapy for equine tendon injuries

Regenerative Medicine With Stem Cell Therapy Injections at an Arizona pain clinic (602) 507-6550

By Stem Cell Treatment

Amniotic Fluid Based Stem Cell Injections are being offered at Preferred Pain Center in Arizona. The injections offer an opportunity to harness the body's regenerative potential and exponentially increase it: 1) Anti-inflammation 2) Hyaluronic Acid 3) Stem Cells 4) Non-steroidal, non-embryonic treatment Pain relief plus potential regeneration of cartilage and soft tissues such as rotator cuff and ligaments. Now at Preferred Pain Center

See the article here:
Regenerative Medicine With Stem Cell Therapy Injections at an Arizona pain clinic (602) 507-6550

Bone Marrow Stem Cells/Gene Therapy

By Stem Cell Treatment

UCLA Life Sciences Public Lecture: "Bone Marrow Stem Cells: Developing New Therapies in the Fight Against Disease"- Donald Kohn, January 18, 2011 Dr. Donald Kohn, UCLA professor of microbiology, immunology and molecular genetics, his research group at the Kohn Lab focus on developing new therapies for genetic diseases of the blood cells using gene therapy methods to correct hematopoietic stem cells. His laboratory performs studies on gene transfer, expression and immune response and then translates the findings into clinical trials.

Excerpt from:
Bone Marrow Stem Cells/Gene Therapy